Giá Trị Tiêu Chuẩn Hóa Trong Khu Vực Hấp Thụ Cao Trên Chẩn Đoán Phát Xạ Positron Với 18F-FRP170 Làm Dấu Ấn Tế Bào Thiếu Oxy Tương Quan Với Áp Suất Oxy Trong Khối U Ở Glioblastoma

Jensen RL (2009) Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 92:317–335 Jensen RL (2006) Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures. Neurosurg Focus 20:E24 Rich JN (2007) Cancer stem cells in radiation resistance. Cancer Res 67:8980–8984 Mendichovszky I, Jackson A (2011) Imaging hypoxia in gliomas. Br J Radiol 84(2):S145–S158 Eschmann SM, Paulsen F, Reimold M et al (2005) Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46:253–260 Kawai N, Maeda Y, Kudomi N et al (2011) Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma. Eur J Nucl Med Mol Imaging 38:441–450 Swanson KR, Chakraborty G, Wang CH et al (2009) Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas. J Nucl Med 50:36–44 Postema EJ, McEwan AJ, Riauka TA et al (2009) Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA). Eur J Nucl Med Mol Imaging 36:1565–1573 Sheehan JP, Popp B, Monteith S et al (2011) Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor. J Neurosurg 115:749–753 Tateishi K, Tateishi U, Sato M et al (2013) Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1alpha expression in patients with glioma. AJNR Am J Neuroradiol 34:92–99 Kaneta T, Takai Y, Kagaya Y et al (2002) Imaging of ischemic but viable myocardium using a new 18F-labeled 2-nitroimidazole analog, 18F–FRP170. J Nucl Med 43:109–116 Ishikawa Y, Iwata R, Furumoto S, Takai Y (2005) Automated preparation of hypoxic cell marker [18F]FRP-170 by on-column hydrolysis. Appl Radiat Isot 62:705–710 Shibahara I, Kumabe T, Kanamori M et al (2010) Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog. J Neurosurg 113:358–368 Matsumoto K, Szajek L, Krishna MC et al (2007) The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography. Int J Oncol 30:873–881 Sorensen M, Horsman MR, Cumming P et al (2005) Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors. Int J Radiat Oncol Biol Phys 62:854–861 Mahy P, De Bast M, Gallez B et al (2003) In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors. Radiother Oncol 67:53–61 Tran LB, Bol A, Labar D et al (2012) Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry. Radiother Oncol 105:29–35 Wang GL, Semenza GL (1995) Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270:1230–1237 Collingridge DR, Piepmeier JM, Rockwell S, Knisely JP (1999) Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol 53:127–131 Kayama T, Yoshimoto T, Fujimoto S, Sakurai Y (1991) Intratumoral oxygen pressure in malignant brain tumor. J Neurosurg 74:55–59 Kaneta T, Takai Y, Iwata R et al (2007) Initial evaluation of dynamic human imaging using 18F-FRP170 as a new PET tracer for imaging hypoxia. Ann Nucl Med 21:101–107 Chapman JD (1979) Hypoxic sensitizers—implications for radiation therapy. N Engl J Med 301:1429–1432 Krohn KA, Link JM, Mason RP (2008) Molecular imaging of hypoxia. J Nucl Med 49(Suppl 2):129S–148S Beppu T, Kamada K, Yoshida Y et al (2002) Change of oxygen pressure in glioblastoma tissue under various conditions. J Neurooncol 58:47–52 Brown JM (1979) Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 52:650–656 Pistollato F, Abbadi S, Rampazzo E et al (2010) Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells 28:851–862 Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 15:297–310 Reischl G, Dorow DS, Cullinane C et al (2007) Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA-first small animal PET results. J Pharm Pharm Sic 10:203–211 Rampling R, Cruickshank G, Lewis AD et al (1994) Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys 29:427–431 Piert M, Machulla H, Becker G et al (1999) Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia. Eur J Nucl Med 26:95–109 Bartlett RM, Beattie BJ, Naryanan M et al (2012) Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats. J Nucl Med 53:1608–1615